UK Markets close in 6 hrs 16 mins

AgeX Therapeutics, Inc. (AGE)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.7667-0.0011 (-0.14%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.7678
Open0.8100
Bid0.7559 x 2900
Ask0.8100 x 1000
Day's range0.7372 - 0.8061
52-week range0.7100 - 3.0600
Volume225,670
Avg. volume78,077
Market cap29.085M
Beta (5Y monthly)1.33
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    AgeX Therapeutics Receives Stock Exchange Deficiency Letter

    ALAMEDA, Calif., November 23, 2021--AgeX Therapeutics , Inc. ("AgeX": NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on November 17, 2021 it received a letter (the "Deficiency Letter") from the staff of the NYSE American (the "Exchange") indicating that AgeX does not meet certain of the Exchange’s continued listing standards as set forth in Section 1003(a)(i) and (ii) of the Exchange Company Guide in that AgeX has stock

  • Business Wire

    AgeX Therapeutics Reports Third Quarter 2021 Financial Results

    ALAMEDA, Calif., November 12, 2021--AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended September 30, 2021.

  • Business Wire

    AgeX Therapeutics Reports Second Quarter 2021 Financial Results

    ALAMEDA, Calif., August 13, 2021--AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended June 30, 2021.